Emerging Trends & Integrated Approaches in Precision Medicine

This event ran on Wednesday May 26, 2021 | 9:00am PST | 12:00am EST

Engager hosted by Agilent Technologies



The May Agilent Technologies Engager will cover:

Emerging Trends & Integrated Approaches in Precision Medicine

Join Agilent Technologies for a deep dive with pharma to discuss the key considerations for successful drug and companion diagnostic co-development and commercialization programs using a broad set of analytical tools.

In this exclusive online event, expert speakers will address key opportunities to integrate different technologies from discovery through clinical trials to global manufacturing and commercialization.


  • As targeted therapies and immuno-oncology treatments continue to evolve, discuss how combining different capabilities such as IHC, FISH, and NGS, and various sample types, can provide greater insights and a more precise diagnosis
  • Learn about the advancements in genomics and how this can complement proteomic technologies to provide diagnostic results that help clinicians better manage and treat disease
  • Get insights from both pharma and CDx providers on clinical diagnostic development from biomarker discovery through global registration and distribution


Anne-Marie Martin, PhD

SVP & Global Head Experimental Medicine Unit Oncology R&D


George Green

Executive Director, Head of Pharmacodiagnostics

Bristol Myers Squibb

Kevin Meldrum

Vice President & General Manager, Genomics Division

Agilent Technologies

Trevor Page, MSc, MBA

Chief Business Officer Companion Diagnostics

Agilent Technologies


This is an event for senior executives from Companion Diagnostics, Translational Medicine and Biomarker & Diagnostics departments of biopharmas looking to refine trial design, increase identification of patient responders and accelerate delivery of the next generation of targeted therapies in areas of high unmet need.


Agilent Technologies Inc. is a global leader in life sciences, diagnostics and applied chemical markets delivering insight and innovation toward improving the quality of life. Agilent instruments, software, services, solutions and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.34 billion in fiscal 2020 and employs 16,400 people worldwide.